Novasel

Novacell Technology is a South Korean biotechnology company specializing in the development of peptide-based therapeutics and molecular diagnostics. The company utilizes its proprietary PS-MIMETIC platform to design functional peptides that target G protein-coupled receptors, specifically focusing on the Formyl Peptide Receptor 2 (FPR2) to modulate inflammatory responses. Its lead candidate, NCP112, is being investigated for the treatment of atopic dermatitis and other chronic inflammatory conditions. Novacell aims to provide next-generation solutions for immune-related diseases through its advanced peptidomimetic technology.